Wojciech Maciej Legiec

head physician

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (5)

Verónica González-Calle

University Hospital of Salamanca

SPAIN

View details

Philippe Moreau

FRANCE

View details

Tamas Masszi

Professor

Semmelweis University

HUNGARY

View details

hareth nahi

Karolinska University Hospital

SWEDEN

View details

Lidia Usnarska-Zubkiewicz

Wroclaw Medical University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wojciech Maciej Legiec

Research Interests

Explore related searches

Contact this professor

Articles (6)

Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma.

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.

Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

Collaborators (5)

Verónica González-Calle

Philippe Moreau

Tamas Masszi

hareth nahi

Lidia Usnarska-Zubkiewicz

Make your next move.